AIUTI Alessandro
Alessandro Aiuti is M.D., specialized in Immunology, and Ph.D. in Molecular and Cell Biology. In 1998 he obtained the National Board in Hematology. Heis Deputy Director, Clinical Research Coordinator, and Head of Unit on Pathogenesis and Therapy of PIDof the San Raffaele Telethon Institute for Gene Therapy in Milan; Director of the Pediatric Immunohematology Unit, […]BELMONT John
Dr. John Belmont Senior Principal Medical Scientist, Illumina, Inc., San Diego, California Professor (Adjunct), Department of Molecular and Human Genetics, and Pediatrics, Baylor College of Medicine, Houston, Texas Dr. Belmont is currently a Senior Principal Medical Scientist in the Medical Genomics Research (MGR) team at Illumina, Inc. At Illumina, Dr. Belmont consults on diverse programs […]DJOUDALBAYE Benjamin
Dr Benjamin Djoudalbaye is Head of Policy and Health Diplomacy at the Africa Centers for Disease Control and Prevention. He was a Senior Health Officer for HIV/AIDS, tuberculosis, malaria and other infectious diseases at the African Union Commission from 2009–2018. He has a strong professional experience in strategic planning, administration, management and evaluation of policies, […]JONKER Anneliene
Anneliene Jonker, PhD, is the Funding and Strategy Officer of the TechMed Centre, at the University of Twente, in Enschede, The Netherlands. In this position, she is responsible for setting up funding strategies for different researchers in the personalized medicine-, medtech, and rare diseases domain, working with academic and industrial researchers. In addition she assists […]PEARCE David A.
David Pearce is President of Innovation and Research for Sanford Health. He completed his undergraduate Bachelor of Science Degree with honors in biological sciences at Wolverhampton Polytechnic in 1986. He gained his PhD in 1990 at the University of Bath, UK, and did postdoctoral training at the University of Rochester, U.S., and Oxford University, UK. […]SCHEEREN Joseph
Dr. Scheeren started his pharmaceutical industry career in 1982 with Servier in Paris, responsible for Regulatory Affairs Northern and Eastern Europe, and Clinical Development in Munich from 1986 – 1987. In 1991, he was appointed Head of Worldwide Regulatory Affairs at Serono, Geneva. In 1992, he took over responsibility of the Global Regulatory Affairs department […]SEYFERT-MARGOLIS Vicki
Vicki Seyfert-Margolis, CEO and Founder of My Own Med, Inc., has published and presented in top journals and numerous conferences about the transformative nature of digital technologies and novel clinical trial designs. Prior to founding My Own Med, Inc., Vicki was appointed in the Obama Administration as the Senior Advisor for Science Innovation and Policy […]VOLK Hans-Dieter
Hans-Dieter Volk, MD, is Professor of Immunology and head of the both Institute of Medical Immunology, Charité Berlin and BIH Center for Regenerative Therapies (BCRT) as well as deputy spokesman of the Berlin-Brandenburg School for Regenerative Therapies (BSRT) (all Berlin, Germany). In addition, he is scientific head of the division Immunology of the Labor Berlin […]WEDELL Anna
Anna Wedell, MD, PhD, is a Clinical Geneticist and Professor of Medical Genetics at the Department of Molecular Medicine & Surgery and Science for Life Laboratory (SciLifeLab), Karolinska Institutet, and Head of the Centre for Inherited Metabolic Diseases (CMMS) at Karolinska University Hospital. Her multidisciplinary team provides nationwide diagnostics, including newborn screening, as well as […]WONG-RIEGER Durhane
DURHANE WONG-RIEGER, PHD is Chair of Rare Disease International, Vice-Chair of Asia Pacific Rare Disease International, member of the Editorial Board of The Patient- Patient Centred Outcomes Research, member of the Global Commission to End the Diagnosis Odyssey for Rare Diseases and member of Health Technology Assessment International Patient /Citizen Involvement Interest Group. In Canada, […]